632 POSTER Randomized phase II study of BMS-247550 (NSC 710428) given daily X 5 days or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: E2301
Burtness B, Manola J, Argiris A, Altieri D, Axelrod R, Forastiere A. 632 POSTER Randomized phase II study of BMS-247550 (NSC 710428) given daily X 5 days or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: E2301. European Journal Of Cancer Supplements 2006, 4: 190-191. DOI: 10.1016/s1359-6349(06)70637-1.Peer-Reviewed Original Research